Abstract:Type 1 Diabetes (T1D) is regarded as an autoimmune disease characterized by insulin deficiency resulting from destruction of pancreatic β-cells. The incidence rates of T1D have increased worldwide. Over the past decades, progress has been made in understanding the complexity of the immune response and its role in T1D pathogenesis, however, the trigger of T1D autoimmunity remains unclear. The increasing incidence rates, immigrant studies, and twin studies suggest that environmental factors play an important role and the trigger cannot simply be explained by genetic predisposition. Several research initiatives have identified environmental factors that potentially contribute to the onset of T1D autoimmunity and the progression of disease in children/young adults. More recently, the interplay between gut microbiota and the immune system has been implicated as an important factor in T1D pathogenesis. Although results often vary between studies, broad compositional and diversity patterns have emerged from both longitudinal and cross-sectional human studies. T1D patients have a less diverse gut microbiota, an increased prevalence of Bacteriodetes taxa and an aberrant metabolomic profile compared to healthy controls. In this comprehensive review, we present the data obtained from both animal and human studies focusing on the large longitudinal human studies. These studies are particularly valuable in elucidating the environmental factors that lead to aberrant gut microbiota composition and potentially contribute to T1D. We also discuss how environmental factors, such as birth mode, diet, and antibiotic use modulate gut microbiota and how this potentially contributes to T1D. In the final section, we focus on existing recent literature on microbiota-produced metabolites, proteins, and gut virome function as potential protectants or triggers of T1D onset. Overall, current results indicate that higher levels of diversity along with the presence of beneficial microbes and the resulting microbial-produced metabolites can act as protectors against T1D onset. However, the specifics of the interplay between host and microbes are yet to be discovered.

The β-Cell Genomic Landscape in T1D: Implications for Disease Pathogenesis

Cracking the type 1 diabetes code: Genes, microbes, immunity, and the early life environment

Immunogenetics of type 1 diabetes: A comprehensive review

Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies

Exploring the Triple Interaction between the Host Genome, the Epigenome, and the Gut Microbiome in Type 1 Diabetes

Genes predisposing to type 1 diabetes mellitus and pathophysiology: a narrative review

Implication of epigenetic factors in the pathogenesis of type 1 diabetes

Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus

The multiple origins of Type 1 diabetes

Beyond Genetics: What Causes Type 1 Diabetes

Type 1 diabetes: immune pathology and novel therapeutic approaches

The Pathogenesis of Type 1 Diabetes

The heterogeneous pathogenesis of type 1 diabetes mellitus

Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes

Gene-environment interaction in the pathophysiology of type 1 diabetes

Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure

Pathomechanisms of Type 2 Diabetes Genes

The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis

Interpreting type 1 diabetes risk with genetics and single-cell epigenomics

Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes?

Genetic risk converges on regulatory networks mediating early type 2 diabetes